| Literature DB >> 36014940 |
Iker Alegria-Lertxundi1, Luis Bujanda2,3,4, Marta Arroyo-Izaga1,5.
Abstract
There is limited evidence to support the relationship between the consumption of animal-source foods other than red meat and processed meat and colorectal cancer (CRC) risk. We aimed to examine the recent available evidence from observational studies about the association between these food groups' intake and CRC risk. For this systematic review, we searched the PubMed database for the last five years. A total of fourteen cohort studies and seven case-control studies comprising a total of >60,000 cases were included. The studies showed a consistent significant decrease in CRC risk, overall and by subsites, associated with a high consumption of total dairy products. Less strong effects associated with the consumption of any subtype of dairy product were observed. Fish consumption, overall and by subtypes (oily or non-oily and fresh or canned), showed a mild inverse association with CRC risk. The association between white meat and egg intake and CRC risk was low and based on a small number of studies; thus, these findings should be interpreted with caution. In conclusion, a high consumption of total dairy products was associated with a lower CRC risk. However, evidence for fish, white meat, and eggs and the CRC risk were not as strong.Entities:
Keywords: adults; case–control studies; cohort studies; colorectal cancer; dairy; eggs; fish; poultry; systematic review; white meat
Mesh:
Year: 2022 PMID: 36014940 PMCID: PMC9412852 DOI: 10.3390/nu14163430
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1PRISMA flow diagram summarizing the identification and selection of the relevant publications about the associations between the consumption of dairy products, fish, white meat, and eggs and the risk of colorectal cancer.
Characteristics of the ten cohort studies included in the systematic review examining the association between the consumption of dairy products and the risk of colorectal cancer.
| Study, Year (Ref.) | Study Cohort, Country | No. Participants (M/W) | No. Incident Cases | Follow-Up Length, y | Exposure | HR (95%CI) | Adjustments to HR | NOS Quality Score |
|---|---|---|---|---|---|---|---|---|
| Bakken et al., 2018 [ | Norway: NOWAC Cohort Study (median, 51) | 81,675 W | 872 CRC (617 CC, 255 RC) | 6 | Total milk: >240 g/day vs. never/seldom | CRC: 0.85 (0.69, 1.05) | Age as the time scale and adjusted for BMI, smoking, processed meat, red meat, hard white cheese, yogurt, fibre from foods, alcohol, and energy intake | 6 |
| Barrubés et al., 2018 [ | Spain: PREDIMED trial (55–80) | 7216 M&W | 97 CRC | 6 | Total dairy products: 564 g/day vs. 206 g/day | CRC: 0.55 (0.31, 0.99) | Stratified by recruitment centre. Adjusted for the intervention group, sex, age, leisure time PA, smoking status, family history of cancer, education level, history of diabetes, use of aspirin treatment, and cumulative average consumption of vegetables, fruits, legumes, cereals, fish, meat, olive oil and nuts, and alcohol | 7 |
| Whole-fat dairy products: 114 g/day vs. 0 g/day | CRC: 1.01 (0.62, 1.64) | |||||||
| Low-fat dairy products: 495 g/day vs. 67 g/day | CRC: 0.62 (0.36, 1,07) | |||||||
| Total yogurt: 128 g/day vs. 8 g/day | CRC: 0.94 (0.56, 1.59) | |||||||
| Low-fat yogurt: 122 g/day vs. 1 g/day | CRC: 1.06 (0.65, 1.73) | |||||||
| Whole-fat yogurt. 45 g/day vs. 0 g/day | CRC: 0.86 (0.51, 1.46) | |||||||
| Cheese: 44 g/day vs. 11 g/day | CRC: 1.23 (0.74, 2.06) | |||||||
| Total milk: 449 g/day vs. 117 g/day | CRC: 0.63 (0.36, 1.10) | |||||||
| Low-fat milk: 407 g/day vs. 15 g/day | CRC: 0.54 (0.32, 0.92) | |||||||
| Whole milk: 60 g/day vs. 0 g/day | CRC: 1.06 (0.64, 1.75) | |||||||
| Concentrated full-fat dairy products: 45 g/day vs. 11 g/day | CRC: 1.11 (0.66, 1.86) | |||||||
| Sugar-enriched dairy products: 14 g/day vs. 0 g/day | CRC: 0.98 (0.55, 1.75) | |||||||
| Fermented dairy products: 166 g/day vs. 36 g/day | CRC: 0.90 (0.53, 1.53) | |||||||
| Vulcan et al., 2018 [ | Sweden: Malmö Diet and Cancer Cohort Study (cases, 60,6+/−7,0; non-cases, 58,0+/−7,6) | 10,966/16,955 | 923 CRC (590 CC, 317 RC, 16 SCRC) | 18 | Total dairy products: | CRC: 0.77 (0.62, 0.96) | Sex, age, method version, season, total energy, education, PA, and BMI | 6 |
| Um et al., 2019 [ | USA: Iowa Women’s Health Study (55–69) | 35,221 W | 1731 CRC (971 PCC, 760 DCC) | 26 | Total dairy products: Q5 vs. Q1 | PCC: 0.87 (0.69, 1.10) | Age, family history of CRC, BMI, smoking, alcohol, PA, HRT use (W), total energy intake, vitamin D, magnesium, fruit and vegetable intake, red and processed meat intake, dietary oxidative balance score, and supplemental calcium | 7 |
| Bradbury et al., 2020 [ | UK: UK Biobank Cohort Study (40–69) | 219,329/256,252 | 2609 CRC | 5.7 | Milk: ≥300 mL/day vs. never | CRC: 0.93 (0.87, 1.01) | Stratified by age, sex, geographical region, and socio-economic status. Adjusted for education, smoking status, waist circumference, height, PA, alcohol intake, family history of CRC, aspirin or ibuprofen use, use of vitamin D and folate supplements, and for W: parity, menopause, OCA, and HRT use | 6 |
| Cheese: ≥5 times/week vs. <once/week | CRC: 1.09 (0.96, 1.23) | |||||||
| Michels et al. 2020 [ | USA: NHS and HPFS (mean at baseline: M 52.3 and W 45.7) | 43,269/83,054 | 2666 CCR * (1965 CC, 579 RC) | 26 M, | Yogurt: never or <1 serving/mo vs. >1 servings/week | CRC: 0.89 (0.80, 1.00) | Age, 2-year follow-up cycle, family history of CRC, history of lower gastrointestinal endoscopy, BMI, height, PA, pack-years of smoking before age 30, current multivitamin use, regular aspirin or NSAIDs use, total caloric intake, alcohol consumption, and energy-adjusted intakes of folate, calcium, vitamin D, total fibre, unprocessed red meat, and processed meat, and for W: parity and age at first birth, menopausal status, age at menopause and HRT | 6 |
| Nilsson et al., 2020 [ | Sweden: VIP and MONICA (25–75) | 53,157/52,734 | 1381 CRC | 20 | Non-fermented milk: Q5 vs. Q1 | CRC (M): 0.87 (0.67, 1.14) | Age, screening year, dairy product category, BMI, civil status, education level, PA in leisure time, smoking status, recruitment cohort (VIP or MONICA), and Qs of fruit and vegetables, alcohol, and energy intake | 8 |
| Fermented milk: Q5 vs. Q1 | CRC (M): 0.98 (0.77, 1.25) | |||||||
| Butter: Q5 vs. Q1 | CRC (M): 0.99 (0.76, 1.28) | |||||||
| Cheese: Q5 vs. Q1 | CRC (M): 0.86 (0.67, 1.10) | |||||||
| Papadimitriou et al., 2021 [ | Europe: EPIC (35–70) | 112,170/274,622 | 5069 CRC | 14.1 | Milk (standardized continuous variable) | CRC: 0.96 (0.93, 0.99) | Total energy intake, smoking status, BMI, PA, diabetes history, education status, age sex, and recruitment centre | 8 |
| Cheese (standardized continuous variable) | CRC: 0.95 (0.92, 0.99) | |||||||
| Yogurt (standardized continuous variable) | CRC: 0.98 (0.95, 1.01) | |||||||
| Deschasaux-Tanguy et al. 2022 [ | France: NutriNet-Santé Cohort Study (42.2+/−14.5) | 21,572/79,707 | 182 CRC | 10 | Total dairy products: continuous per 1 serving increment | CRC: 1.05 (0.93, 1.19) | Age, sex, height, BMI, baseline type 2 diabetes, prevalent hypertriglyceridemia, hypercholesterolemia, energy intake without alcohol, sugar intake, sodium intake, fruits and vegetables intake, whole foods, red and processed meat consumption, non-dairy calcium intake, non-dairy SFA intake, alcohol intake, number of 24 h dietary records, smoking status, educational level, PA and family history of cancer | 6 |
| Milk: continuous per 1 serving increment | CRC: 0.92 (0.74, 1.15) | |||||||
| Yogurt: continuous per 1 serving increment | CRC: 0.90 (0.67, 1.19) | |||||||
| Cheese: continuous per 1 serving increment | CRC: 1.10 (0.9, 1.30) | |||||||
| CRC: 1.39 (1.09, 1.77) | ||||||||
| Fermented dairy products: continuous per 1 serving increment | CRC: 1.10 (0.96, 1.27) | |||||||
| Sugary dairy dessert: continuous per 1 serving increment | CRC: 1.58 (1.01, 2.46) | |||||||
| Kakkoura et al. 2022 [ | China: China Kadoorie Biobank Study (35–74) | 205,000/295,000 | 3350 CRC | 10.8 | Total dairy products: | CRC: 1.00 (0.94, 1.06) | Stratified by age-at-risk, sex, and individual regions. Adjusted for education, income, smoking, alcohol consumption, total PA, family history of cancer, fresh fruit consumption, soy consumption, and BMI | 8 |
| Monthly intake | CRC: 1.10 (1.00, 1.21) | |||||||
| Regular intake | CRC: 1.09 (1.01, 1.18) | |||||||
| Per 50 g/day of usual intake | CRC: 1.08 (1.00, 1.17) |
BMI: body mass index; CC: colon cancer; CI: confidence interval; CRC: colorectal cancer; DCC: distal colon cancer; EPIC: European Prospective Investigation into Cancer and Nutrition; HPFS: Health Professionals Follow-Up Study; HR: hazard ratio; HRT: hormone replacement therapy; M: men; mo: moth; MONICA: Northern Sweden Monitoring of Trends and Determinants in Cardiovascular disease; NHS: Nurses’ Health Study; NSAIDs: non-steroidal anti-inflammatory drugs; NOS: Newcastle-Ottawa Scale; NOWAC: Norwegian Women and Cancer; OCA: oral contraceptive agent; PA: physical activity; PCC: proximal colon cancer; PREDIMED: PREvención con DIeta MEDiterránea Study; Q: quintile; RC: rectal cancer; SCRC: synchronous colon and rectal cancer; SFA: saturated fatty acid; VIP: Västerbotten Intervention Programme; W: women. * One hundred and twenty-two cases with unknown sites within the colorectum.
Characteristics of the three case–control studies included in the systematic review examining the association between the consumption of dairy products and the risk of colorectal cancer.
| Study, Year (Ref.) | Country | No. Cases and Endpoint | Sex, No. of Cases (M/W) | No. Controls and Type | Exposure | OR (95% CI) | Adjustments to OR | NOS Quality Score |
|---|---|---|---|---|---|---|---|---|
| Alegria-Lertxundi et al., 2020 [ | Spain (50–69) | 308 CRC (74 PCC, 234 DCC) | 204/104 | 308 C | Milk/dairy products: T3 vs. T1 | CRC: 1.80 (0.95, 3.42) | Age, sex, BMI, energy intake, physical exercise level, smoking status and intensity of smoking, Deprivation Index, and Predictive Risk Modelling, including all the mean food groups (red and processed meat, fish, eggs, fibre-containing foods, nuts, fat, sweets and added sugar, and alcoholic beverage) | 7 |
| Fresh cheese: T3 vs. T1 | CRC: 0.92 (0.58, 1.46) | |||||||
| Other cheeses: T3 vs. T1 | CRC: 1.87 (1.11, 3.16) | |||||||
| Zhang et al., 2020 [ | China (30–75) | 2380 CRC (1476 CC, 828 RC, and 76 SCRC) | 1356/102 | 2389 H | Total dairy products: T3 vs. T1 | CRC: 0.32 (0.27, 0.39) | Age, sex, marital status, residence, educational level, occupation, income level, occupational activity, household and recreational PA, smoking status, alcohol drinking, family history of cancer, BMI, total energy intake, vegetable, fruit, red meat, and dietary fibre intake, and for W: age at menarche | 7 |
| Milk, drink vs. not drink | CRC: 0.52 (0.45, 0.59) | |||||||
| Collatuzzo et al., 2022 [ | Iran (controls, 57.2+/−11.5; cases, 58.6+/−12.4) | 865 CRC a (434 CC, 404 RC) | 497/368 | 3205 C | Total dairy products: T3 vs. T1 | CRC: 1.06 (0.85, 1.32) | Sex, age, BMI, smoking, opium, province, aspirin, SES, PA, use of red and processed meat, fat intake, fibre intake | 5 |
| Yogurt: T3 vs. T1 | CRC: 0.96 (0.77, 1.20) | |||||||
| Milk: T3 vs. T1 | CRC: 0.98 (0.79, 1.21) | |||||||
| Dough: T3 vs. T1 | CRC: 1.26 (0.98, 1.61) | |||||||
| Kashk: T3 vs. T1 | CRC: 1.03 (0.81, 1.31) | |||||||
| Cheese: T3 vs. T1 | CRC: 1.08 (0.81, 1.44) | |||||||
| Cream: T3 vs. T1 | CRC: 1.33 (1.08, 1.64) | |||||||
| Ice cream: T3 vs. T1 | CRC: 0.86 (0.62, 1.21) | |||||||
| Other milk products: T3 vs. T1 | CRC: 1.00 (0.73, 1.37) |
BMI: body mass index; C: community controls; CC: colon cancer; CI: confidence interval; CRC: colorectal cancer; DCC: distal colon cancer; H: hospital controls; M: men; NOS: Newcastle-Ottawa Scale; PA: physical activity; PCC: proximal colon cancer; RC: rectal cancer; SES: socioeconomic status; SCRC: synchronous colon and rectal cancer; T: tertile; W: women. a Twenty-seven cases with unknown sites within the colorectum.
Summary of the findings found in the reviewed articles examining the association between the consumption of dairy products and the risk of colorectal cancer.
| Food Type | Cohort Studies | Case-Control studies | ||
|---|---|---|---|---|
| No. of Total Studies (Ref.) | No. of Studies (Ref.), Type of Association, Food Subtype a, CRC Overall or Subsites Risk b | No. of Total Studies (Ref.) | No. of Studies (Ref.), Type of Association, Food Subtype a, CRC Overall or Subsites Risk b | |
| Total dairy products in overall | 5 [ | 3 [ | 3 [ | 1 [ |
| Total dairy products by fat content | 1 [ | |||
| Total milk in overall | 5 [ | 2 [ | 1 [ | |
| Total milk by fat content | 1 [ | 1 [ | ||
| Yogurt and other fermented dairy products | 4 [ | 1 [ | 1 [ | |
| Cheese | 4 [ | 1 [ | 2 [ | 1 [ |
| Other dairy products | 3 [ | 1 [ | 1 [ | 1 [ |
CC: colon cancer; CRC: colorectal cancer; DCC: distal colon cancer; PCC: proximal colon cancer; a If applicable; b The rest of the studies showed no significant effect.
Characteristics of the five cohort studies included in the systematic review examining the association between the consumption of fish, white meat, and eggs and the risk of colorectal cancer.
| Study, Year (Ref.) | Study Cohort, Country (Age, y) | No. Participants (M/W) | No. Incident Cases (M/W) | Follow-Up Length, y | Exposure | HR (95%CI) | Adjustments to HR | NOS Quality Score |
|---|---|---|---|---|---|---|---|---|
| Aglago et al., 2020 [ | EPIC, 10 European countries (cases, 57.3+/−7.9; controls, 51.2+/−9.95) | 142,241/333,919 | 2719/3572 | 14.9 | Total fish and shellfish: Q5 vs. Q1 | CRC: 0.88 (0.80, 0.96) | Stratified by age, sex, and centre. Adjusted for BMI, height, PA, smoking, education, and intakes of energy, alcohol, red and processed meat, fibre, and dairy products | 7 |
| Oily fish: Q5 vs. Q1 | CRC: 0.90 (0.82, 0.98) | |||||||
| Non-oily fish: Q5 vs. Q1 | CRC: 0.91 (0.83, 1.00) | |||||||
| Bradbury et al., 2020 [ | UK Biobank Cohort Study, UK (40–69) | 219,329/256,252 | 2609 | 5.7 | Total fish: ≥3 times/week vs. <once/week | CRC: 0.95 (0.80, 1.13) | Stratified by age, sex, geographical region, and SES. Adjusted for education, smoking status, waist circumference, height, PA, alcohol intake, family history of CRC, aspirin or ibuprofen use, use of vitamin D and folate supplements and for W: parity, menopause, OCA and HRT use | 6 |
| Poultry: ≥2 times/week vs. never | CRC: 0.96 (0.79, 1.18) | |||||||
| Knuppel et al., 2020 [ | UK Biobank Cohort Study, UK (37–73) | 218,498/256,498 | 28,955 | 6.9 | Poultry: per 30 g/day | CRC: 1.02 (0.91, 1.14) | Stratified for sex, age group, region; and adjusted for age, ethnicity, deprivation, qualification, employment, living with a spouse or partner, height, smoking, PA, alcohol intake, total fruit and vegetable intake, estimated cereal fibre intake, BMI, and for W: menopausal status, parity, HRT and OCA use | 7 |
| Mejborn et al., 2021 [ | The Danish National Survey on Diet and Physical Activity cohort study, Denmark (>50) | 3033/3249 | 127 CRC | 8.7 | Poultry: ≥16 g/day vs. <16 g/day | CRC: 1.62 (1.13, 2.31) | Sex, educational attainment, ethnicity, smoking, PA, alcohol, BMI, and total energy intake | 7 |
| Wang et al., 2022 [ | NHS, NHSII, and HPFS, USA (M, 40–75; W, 25–42) | 527/4742 | 404 CC, 122 RC | 30 | Total fish: 1 SD, MPS | CRC: OR, 0.86 (0.78, 0.96) | BMI, family history of CRC, endoscopy, multivitamin use, aspirin use, smoking, PA, total energy intake, alcohol intake, and modified AHEI (in NHS/HPFS) | 6 |
| Poultry: 1 SD, MPS | CRC: OR, 0.94 (0.85, 1.05) |
AHEI: alternate healthy eating index; BMI: body mass index; CC: colon cancer; CRC: colorectal cancer; DCC: distal colon cancer; EPIC: European Prospective Investigation into Cancer and Nutrition; HPFS: Health Professional Follow-up Study; HR: hazard ratio; HRT: hormone replacement therapy; M: men; MPS: metabolic profile score; NHS: Nurses’ Health Study; NOS: Newcastle–Ottawa Scale; OCA: oral contraceptive agent; OR: odds ratio; PA: physical activity; PCC: proximal colon cancer; Q: quintile; RC: rectal cancer; SD: standard deviation; SES: socioeconomic status; W: women.
Characteristics of the five case–control studies included in the systematic review examining the association between the consumption of fish, white meat, and eggs and the risk of colorectal cancer.
| Study, Year (Ref.) | Country (Age, y) | No. Cases and Endpoint | Sex, No. of Cases (M/W) | No. Controls and Type | Exposure | OR (95% CI) | Adjustments to OR | NOS Quality Score |
|---|---|---|---|---|---|---|---|---|
| Deoula et al., 2019 [ | Morocco (≥18) | 1453 CRC | 716/737 | 1453 C | White meat: >308 g/week vs. ≤308 g/week | CRC: 1.07 (0.96, 1.19) | Age, residence, education level, monthly income, PA intensity, smoking status, BMI, NSAIDs, total energy intake, calcium, dietary fibre, family history of CRC, dairy product, fruits, vegetable, fish, and alcohol consumption | 6 |
| Turkey: >51 g/week vs. ≤51 g/week | CRC: 0.89 (0.80, 1.01) | |||||||
| Poultry: >196 g/week vs. ≤196 g/week | CRC: 1.10 (0.99, 1.23) | |||||||
| Kim et al., 2019 [ | Republic of Korea (cases, 56.6+/−9.7; controls, 56.1+/−9.1) | 923 CRC | 625/298 | 1846 C | Total fish and shellfish: T3 vs. T1 | CRC: 1.04 (0.82, 1.32) | Total energy intake, BMI, first-degree family history of CRC, occupation, educational level, monthly income, marital status, regular exercise, and alcohol consumption | 6 |
| Alegria-Lertxundi et al., 2020 [ | Spain (50–69) | 308 CRC (234 DCC, 74 PCC) | 204/104 | 308 C | Eggs: T3 vs. T1 | CRC: 1.26 (0.71, 2.23) | Age, sex, BMI, energy intake, physical exercise level, smoking status and intensity of smoking, Deprivation Index, and Predictive Risk Modelling, including all the mean food groups (red and processed meat, fibre-containing foods, nuts, fat, sweets and added sugar, and alcoholic beverage) | 7 |
| Total fish: T3 vs. T1 | CRC: 1.25 (0.68, 2.29) | |||||||
| Shen et al., 2021 [ | China (cases, 60.3+/−13.4; controls, 59.6+/−12.9) | 100 CRC | 54/46 | 100 C | Eggs: ≥280 g/week vs. <280 g/week | CRC: 0.26 (0.10, 0.69) | Age, BMI | 4 |
| White meat: >500 g/week vs. ≤500 g/week | CRC: 0.86 (0.30, 2.46) | |||||||
| Franchi et al., 2022 [ | Italy (50–69) | 2419 CRC (727 DCC, 373 PCC) | 1432/987 | 4723 H | Total fish (canned and non-canned) vs. no fish | CRC: 0.69 (0.58, 0.81) | Centre, study, sex, age, BMI, education, family history of CRC, PA at work, smoking habits, alcohol consumption, vegetable and fruit consumption, and energy intake | 5 |
| Non-canned fish vs. no fish | CRC: 0.88 (0.77, 1.00) | |||||||
| Only canned fish vs. no fish | CRC: 0.77 (0.62, 0.97) | |||||||
| Canned fish: ≥2 servings/week vs. <1 serving/week | CRC: 0.86 (0.51, 0.85) | The same as in the previous row plus fish consumption |
BMI: body mass index; C: community controls; CC: colon cancer; CI: confidence interval; CRC: colorectal cancer; DCC: distal colon cancer; H: hospital controls; M: men; NOS: Newcastle–Ottawa Scale; NSAIDs: non-steroidal anti-inflammatory drugs; OR: odds ratio; PA: physical activity; PCC: proximal colon cancer; R: rectal cancer; T: tertile; W: women.
Summary of the findings found in the reviewed articles examining the association between the consumption of fish, white meat, and eggs and the risk of colorectal cancer.
| Food Type | Cohort Studies | Case-Control Studies | ||
|---|---|---|---|---|
| No. of Total Studies (Ref.) | No. of Studies (ref.), Type of Association, CRC Overall or Subsites Risk a | No. of Total Studies (Ref.) | No. of Studies (Ref.), Type of Association, CRC Overall or Subsites Risk a | |
| Total fish | 3 [ | 2 [ | 3 [ | 1 [ |
| Oily fish | 2 [ | 2 [ | 1 [ | 1 [ |
| Non-oily fish | 1 [ | 1 [ | 1 [ | |
| Canned fish | 1 [ | 1 [ | 1 [ | 1 [ |
| White meat | 1 [ | 1 [ | ||
| Poultry | 4 [ | 1 [ | 1 [ | 1 [ |
| Turkey | 1 [ | |||
| Egg | 2 [ | 1 [ | ||
CC: colon cancer; CRC: colorectal cancer; DCC: distal colon cancer; M: men; PCC: proximal colon cancer; RC: rectal cancer; W: women. a The rest of the studies showed no significant effects.